Abstract:Background: Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide. Early detection of CRC can significantly reduce its mortality rate. Current method of CRC diagnosis relies on the invasive endoscopy. Non-invasive assays including fecal occult blood testing (FOBT) and fecal immunological test (FIT) are compromised by low sensitivity and specificity, especially at early stages. Thus, a non-invasive and accurate approach for CRC screening would be highly desirable. Results: A new qPCR-based assay combining the simultaneous detection of the DNA methylation status of ten candidate genes was used to examine plasma samples from 56 normal controls, 6 hyperplastic polys, 9 non-advanced adenomas (NAAs), 22 advanced adenomas (AAs) and 175 CRC patients, using 10 ng of cfDNA. We further built a logistic regression model for CRC diagnosis. We tested ten candidate methylation markers including twist1, vav3-as1, fbn1, c9orf50, sfmbt2, kcnq5, fam72c, itga4, kcnj12 and znf132. All markers showed moderate diagnostic performance with AUCs ranging from 0.726 to 0.815. Moreover, a 4-marker model, comprised of two previously reported markers (c9orf50 and twist1) and two novel ones (kcnj12 and znf132), demonstrated high performance for detecting colorectal cancer in an independent validation set (N = 69) with an overall AUC of 0.911 [95% confidence interval (CI) 0.834-0.988], sensitivity of 0.800 [95% CI 0.667-0.933] and specificity of 0.971 [95% CI 0.914-1.000]. The stage-stratified sensitivity of the model was 0.455 [95% CI 0.227-0.682], 0.667 [95% CI 0.289-1.000], 0.800 [95% CI 0.449-1.000], 0.800 [95% CI 0.449-1.000] and 0.842 [95% CI 0.678-1.000] for advanced adenoma and CRC stage I-IV, respectively. Conclusion: kcnj12 and znf132 are two novel methylation biomarkers for CRC diagnosis. The 4-marker methylation model provides a new non-invasive choice for CRC screening and interception.

Non-invasive diagnosis of early chronic colitis cancerization via amplified sensing of miRNA-21 in NIR-IIb window

Quantitative Imaging of MicroRNA‐21 In Vivo for Real‐Time Monitoring of the Cancer Initiation and Progression

CD24-Targeted NIR-II Fluorescence Imaging Enables Early Detection of Colorectal Neoplasia

A NIR Programmable in Vivo Mirna Magnifier for NIR-II Imaging of Early Stage Cancer.

Near-infrared light-assisted dual-modal photoelectrochemical and photo-fuel-cell-driven self-powered biosensor for detection of miRNA-21 in living cancer cells

Detection of intracellular microRNA-21 for cancer diagnosis by a nanosystem containing a ZnO@polydopamine and DNAzyme probe

3D hierarchic interfacial assembly of Au nanocage@Au along with IS-AgMNPs for simultaneous, ultrasensitive, reliable, and quantitative SERS detection of colorectal cancer related miRNAs

ECL and Visual Dual-Mode Detection of Mirna-21 Based on HRP/Au NPs Composite Probe and CRISPR/Cas12a Strategy

Ratiometric Fluorescence Detection of Colorectal Cancer-Associated Exosomal miR-92a-3p with DSN-Assisted Signal Amplification by a MWCNTs@Au NCs Nanoplatform

Detection of Microrna-21 Based on Smartly Designed Ratiometric Electrochemical Sensor and Dual-Signal Amplification

Plasmonic nanobiosensors for detection of microRNA cancer biomarkers in clinical samples

Visual and Colorimetric Detection of Microrna in Clinical Samples Based on Strand Displacement Amplification and Nanozyme-Mediated CRISPR-Cas12a System

A LoC-SERS platform based on triple signal amplification for highly sensitive detection of colorectal cancer miRNAs

Gold Nanoparticle-Based Enzyme-Assisted Cyclic Amplification for the Highly-Sensitive Detection of miRNA-21

Signal-on Electrogenerated Chemiluminescence Biosensor for Ultrasensitive Detection of Microrna-21 Based on Isothermal Strand-Displacement Polymerase Reaction and Bridge DNA-gold Nanoparticles.

Sensitive detection of colorectal cancer in peripheral blood by a novel methylation assay

High-precision detection and navigation surgery of colorectal cancer micrometastases

Sensitive Fluorescent Detection of Exosomal Microrna Based on Enzymes-Assisted Dual-Signal Amplification

Detection Of The Braf V600e Mutation In Colorectal Cancer By Nir Spectroscopy In Conjunction With Counter Propagation Artificial Neural Network

The carbon dots with near-infrared electrochemiluminescence emission and low excitation potential for ultrasensitive analysis of microRNA-222

Dual Energy Transfer-Based Fluorescent Nanoprobe For Imaging Mir-21 In Nonalcoholic Fatty Liver Cells With Low Background